HCPCS code Q5147 — Inj, aflibercept-ayyh, 1 mg. Status: Active. Effective Apr 1, 2025. Source: CMS HCPCS Level II.

Q5147

Active

Inj, aflibercept-ayyh, 1 mg

Injection, aflibercept-ayyh (pavblu), biosimilar, 1 mg

Category: Temporary
Section: Q-codes: Temporary Codes
Effective: Apr 1, 2025
Code type: alphanumeric
OPPS Status: G — Pass-through drugs and biologicals
OPPS APC: 2068

MUE — Medically Unlikely Edits

Maximum units of Q5147 Medicare will pay for one beneficiary on one date of service. Claims exceeding the MUE are denied or returned for review.

Service Type Max Units / Day
DME Supplier 4
Outpatient Hospital 4
Practitioner Services 4

Source: CMS Medicare NCCI Medically Unlikely Edits

NDC Crosswalk

National Drug Codes (NDCs) mapped to this HCPCS code.

NDC Drug Name
55513-0056-01 Pavblu
55513-0065-01 Pavblu

Change History

Quarterly changes published by CMS. Revisions may affect the code description, coverage, or rate — review each quarter's changes before submitting claims.

  • New Code 2025-Q2
    Inj, aflibercept-ayyh, 1 mg